IBAB Ion Beam Applications SA

IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day

IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day



Louvain-la-Neuve, Belgium, 04 April, 2025 –  (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will be hosting a Capital Markets Day (CMD) this coming Monday 7 April from 2pm to 5:00pm CEST (8am ET to 11:00am ET) at its headquarters in Louvain-la-Neuve, Belgium, and via live webcast.

At the event IBA’s management team will outline the company’s strategic roadmap and long-term growth ambitions. The agenda is outlined below:

  • Webcast open: 2pm
  • Purpose, Vision & Strategy​​
  • Business Review – Execution Plan & Opportunities​​
    • Industrial Solutions
    • RadioPharma Solutions
    • Engineering & Supply Chain
    • Proton Therapy
    • Dosimetry
    • New Ventures
  • Financials & Outlook
  • Webcast close: 5pm

To attend via webcast, register via this . Please complete the registration at least 15 minutes before the start of the event. No new material financial information will be delivered during the CMD.

The presentation will be made available on IBA’s website ahead of the event on and a recording will also be made available shortly afterwards on the same page and on .

For further information, please contact ICR Healthcare at .   

***ENDS***

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as the most advanced form of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,100 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at:

CONTACTS

Olivier Lechien

Corporate Communication Director



ICR Healthcare

Amber Fennell, Angela Gray, Lucy Featherstone

+44 (0) 20 3709 5700

Attachment



EN
04/04/2025

Underlying

IBABIon Beam Applications SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – Transparency Notification - Denominator

IBA – Transparency Notification - Denominator                                                                                                                   June 30th, 2025 Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various provisions (Belgian Gazette 12.VI.2007) (hereinafter, the “Law”). Under this provision:  « [...] the issuer publishes the total capital, the total number of securities conferring the right to vote and voting rights, as...

June 30, 2025 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – Notification de Transparence - Dénominateur

IBA – Notification de Transparence - Dénominateur 30 juin 2025 Publication effectuée en vertu de l’article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes dans des émetteurs dont les actions sont admises à la négociation sur un marché réglementé et portant des dispositions diverses (M.B. 12.VI.2007) (ci-après, la « Loi »). En vertu de cette disposition : « [...] l'émetteur publie le total du capital, le nombre total de titres conférant le droit de vote et de droits de vote, ainsi que, par catégorie, le nombre de titres conférant le droit de vote et de ...

June 30, 2025 1 EN
Guy Sips ... (+2)
  • Guy Sips
  • Michiel Declercq
PROX PROXIMUS SA DE DROIT PUBLIC
IBAB ION BEAM APPLICATIONS SA
SPEC SMARTPHOTO GROUP
06/18/25 June 18, 2025 1 EN
ING Helpdesk
  • ING Helpdesk
PROX Proximus SA de ...
IBAB Ion Beam Applic...

Benelux Morning Notes

IBA: Large X-ray sterilisation solution sale Proximus: Stijn Bijnens new CEO of Proximus

PROX PROXIMUS SA DE DROIT PUBLIC
IBAB ION BEAM APPLICATIONS SA
06/18/25 June 18, 2025 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

Steri-Tek to boost sterilization capacity of its Texas-based center fi...

Steri-Tek to boost sterilization capacity of its Texas-based center fivefold with IBA’s X-ray irradiation system Louvain-la-Neuve, Belgium, June 18, 2025 –  (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial advanced irradiation, announced today it has signed a contract with Steri-Tek, a growing irradiation services provider, to install a fully-integrated Be Wide X-ray Solution. IBA’s solution will be installed at Steri-Tek’s service center near Dallas-Fort Worth Metro Area, Texas, which was op...

June 18, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch